Aclaris Therapeutics Inc. – State Reviewer

Companies

Aclaris Therapeutics Inc. (NASDAQ:ACRS) Stock: Worth Taking a Bite?

Aclaris Therapeutics Inc. (NASDAQ:ACRS) previous close was $17.83 while the outstanding shares total 50.34M. The firm has a beta of 0.65. ACRS’s shares traded lower

Industry

Is Aclaris Therapeutics Inc. (NASDAQ:ACRS) Still Worth A Bite?

Aclaris Therapeutics Inc. (NASDAQ:ACRS) shares traded lower over the last trading session, losing -5.30% on 06/09/21. The shares fell to a low of $16.82 before

Companies

Aclaris Therapeutics Inc. (ACRS) moved up 0.74%: Aclaris Therapeutics Inc. Price Paint Picture of volatility

Aclaris Therapeutics Inc. (NASDAQ:ACRS) Relative Strength Index (RSI) is 44.57, with weekly volatility at 6.62% and ATR at 1.35. The ACRS stock’s 52-week price range

Markets

Is Aclaris Therapeutics Inc. (NASDAQ:ACRS) Still Worth A Bite?

Aclaris Therapeutics Inc. (NASDAQ:ACRS) shares fell to a low of $20.89 before closing at $21.03. Intraday shares traded counted 0.52 million, which was 10.9% higher

Tag: Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc. (NASDAQ:ACRS) Stock: Worth Taking a Bite?

Is Aclaris Therapeutics Inc. (NASDAQ:ACRS) Still Worth A Bite?

Aclaris Therapeutics Inc. (ACRS) moved up 0.74%: Aclaris Therapeutics Inc. Price Paint Picture of volatility

Is Aclaris Therapeutics Inc. (NASDAQ:ACRS) Still Worth A Bite?

Quick Links

Categories